Loss of ini 1 protein expression

Clinical trials for Loss of ini 1 protein expression explained in plain language.

Never miss a new study

Get alerted when new Loss of ini 1 protein expression trials appear

Sign up with your email to follow new studies for Loss of ini 1 protein expression, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Terminated 1

Immunotherapy combo tested for rare kidney cancer, but trial stopped early

Disease control Stopped early

This phase II trial tested two immunotherapy drugs, nivolumab and ipilimumab, in 10 people with a rare and aggressive kidney cancer called renal medullary carcinoma. The goal was to see if the drugs could shrink tumors or slow cancer growth. However, the study was terminated earl…

Matched conditions: LOSS OF INI 1 PROTEIN EXPRESSION

Phase 2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Aug 22, 2026 00:00 UTC

Loss of ini 1 protein expression

Get alerted when new Loss of ini 1 protein expression trials appear

Immunotherapy combo tested for rare kidney cancer, but trial stopped early